Patel Sanjiv
President and CEO
Patel Sanjiv has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Sep 9, 2026.
On the most recent filing, Patel Sanjiv is listed as President and CEO at Relay Therapeutics, Inc. Inside the rolling window, Patel Sanjiv reported no open-market purchases and 5 open-market sales totaling $3.6M in RLAY. The largest disclosed transaction in the window is a sale of 48,199 RLAY shares on Aug 17, 2026, worth $980K.
Companies traded
Other insiders at RLAY
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Patel Sanjiv made?
Patel Sanjiv has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Patel Sanjiv trade?
Patel Sanjiv has filed SEC Form 4 disclosures for 1 company, including RLAY.
When was Patel Sanjiv's most recent SEC Form 4 filing?
Patel Sanjiv's most recent SEC Form 4 filing on Tracefour is dated Sep 9, 2026.
What is Patel Sanjiv's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Patel Sanjiv is listed as President and CEO.
What is Patel Sanjiv's total buy and sell value in the current window?
Inside the rolling retention window, Patel Sanjiv bought $0 and sold $3.6M based on SEC Form 4 filings.
What was Patel Sanjiv's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 48,199 RLAY shares on 2026-08-17, worth $980K, per SEC Form 4 filings.